Pulmonology
Physician discussions on respiratory conditions, critical care, interstitial lung disease, and pulmonary procedures.
Recent Discussions
Do you routinely monitor imaging or pulmonary function in patients with pulmonary TB after the completion of therapy?
The simple answer will be: NO.
Do you rule out TB in patients with AIDS and lobar pneumonia?
Depends: +Ve Risk Factors: Travel/contact Hx, recent Quantiferon Conversion, changing CXR, Night sweats Unexplained low-grade temps Then, yes. Otherwise, no.
Does your approach to treating latent tuberculosis differ in a patient on anti-fibrotic therapy?
With the increasingly common indication of progressive pulmonary fibrosis in the setting of CT-ILD, RA, and scleroderma, it is conceivable that patients being started on antifibrotic therapy may be on anti-TNF alpha or other immunosuppressive agents. Specifically with anti-TNF alpha agents such as R...
Are you using the microbial cell-free DNA “Karius” test to aid in the diagnosis of an atypical pulmonary infection such as PJP or NTM?
No, not at this time. Intriguing, but not sure we know enough yet.
Do you consider use of convalescent plasma early in disease course in COVID-19 induced ARDS in mechanically ventilated patients?
At this time, I have not adopted the use of convalescence plasma in COVID-19-induced ARDS. I have read the Belgian study but I believe more evidence from other similar studies is needed before we accept it as standard of care. I have not seen any COVID-19-induced ARDS for almost 18 months.
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
Usual Interstitial Pneumonia or UIP is among the most serious forms of RA-associated lung disease. Clinical studies have demonstrated that its prognosis is similar to idiopathic pulmonary fibrosis (IPF). UIP is extremely challenging to treat and we have learned from experience that our DMARDs and bi...
Do you routinely use inhaled pulmonary vasodilators in the management of patients with ARDS with refractory hypoxemia?
No, as of right now it is not routinely used. There are some early animal models that suggest benefits, but other small clinical trials conducted over the last few years haven’t been able to show benefits. Some providers have inhaled iloprost or inhaled nitric as the last resort when nothing else se...
How are you navigating approval of CPAP for patients with a high suspicion for OSA on chronic oxygen who are unable to complete an in-lab PSG?
This is a challenging situation for both patient and healthcare provider. The physician is to be applauded for making efforts to get this patient appropriate care despite the very difficult situation to navigate. Of course, the best outcome will occur if we can find a way to get this patient in for ...
Is a larger bore percutaneous chest tube sufficient to adequately drain a hemothorax, or is a surgical chest tube required?
A pigtail is frequently sufficient for hemothorax. There are studies suggesting there was no obvious advantage of larger chest tubes over smaller size chest tubes in hemothorax. There are also studies to support the use of tPA in hemothorax to facilitate the drainage.
Do you routinely use hypertonic saline for pulmonary toileting in patients with non-CF bronchiectasis?
We routinely use hypertonic saline (3% or 7%) inhaled twice daily with oscillatory PEP therapy in non-CF bronchiectasis. The Aerobika device is helpful as the saline can be directly administered through the device with an Aeroeclipse nebulizer, which many patients find more beneficial. I have found ...